Price $3.51 |
Market Cap
236.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.5
|
P/S
53.0
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-68.3K
|
FCF
-0.8
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-40.90%
|
ROI
-41.20%
|
|
ROA
-37.20%
|
EPS Growth
15.20%
|
Current Ratio
11.1
|
Debt/Equity
1.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc (INM) | $0.38 | - | - | 1.6M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $0.63 | - | - | 16.4M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $1.44 | - | - | 12.8M | Strong Buy |
| Pharmacyte Biotech Inc (PMCB) | $2.25 | - | - | 18.9M | Strong Buy |
| Airsculpt Technologies Inc (AIRS) | $5.88 | - | - | 339.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
